Richard has over 20 yrs experience and is an internationally acknowledged Environmental Risk Assessment (ERA) expert specialising in pharmaceuticals and general chemicals. Previously Head of Global ERA at AstraZeneca, Brixham until he joined RSA in 2016, Richard has the ability to lead multi-functional teams and >30 major client projects while at AstraZeneca.

Richard is a highly customer-focused and experienced Project Manager with a proven track record of delivering quality outputs to meet client and regulatory needs. Richard has a highly analytical, ‘fit for purpose’ mind-set and clear presentation and writing skills.

Richard has extensive experience with small molecules in the oncology therapeutic area. Oncology drugs often have several characteristics which require special consideration with respect to environment (highly potent, often cytotoxic, endocrine active etc.).